切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 89 -92. doi: 10.3877/cma.j.issn.1674-1358.2019.02.001

所属专题: 文献

综述

高毒力肺炎克雷伯菌研究进展
陈辞言1, 杜艳1,()   
  1. 1. 650032 昆明市,昆明医科大学第一附属医院检验科、云南省实验诊断研究所、中国云南省检验医学重点实验室
  • 收稿日期:2018-09-14 出版日期:2019-04-15
  • 通信作者: 杜艳
  • 基金资助:
    2017年云南省医学学科带头人培养项目(No. D-2017023)

Progress on hypervirulent Klebsiella pneumoniae

Ciyan Chen1, Yan Du1,()   

  1. 1. Department of Clinical Laboratory, The First Affiliated Hospital of Kunming Medical University; Yunnan Institute of Laboratory Diagnosis; Yunnan Key Laboratory of Laboratory Medicine, Kunming 650032, China
  • Received:2018-09-14 Published:2019-04-15
  • Corresponding author: Yan Du
  • About author:
    Corresponding author: Du Yan, Email:
引用本文:

陈辞言, 杜艳. 高毒力肺炎克雷伯菌研究进展[J]. 中华实验和临床感染病杂志(电子版), 2019, 13(02): 89-92.

Ciyan Chen, Yan Du. Progress on hypervirulent Klebsiella pneumoniae[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(02): 89-92.

肺炎克雷伯菌(KP)为常见的医院获得性和社区获得性感染病原菌,近年来肺炎克雷伯菌所致的肝脓肿患者例数逐渐增加,且多伴随肝外感染,故得到了广泛关注。这种引起肝脓肿的肺炎克雷伯菌具有较高毒力以及高黏液特性,易导致健康个体感染,因此将其定义为高毒力肺炎克雷伯菌(hvKP)。高毒力肺炎克雷伯菌感染的临床特点、对抗菌药物的敏感性以及分子生物学特性,均不同于传统的肺炎克雷伯菌(cKP),故对高毒力肺炎克雷伯菌的毒力基因进行研究有助于明确该细菌的致病机制,有助于尽早诊断和治疗该细菌导致的感染,有效改善高毒力肺炎克雷伯菌感染者的预后。

Klebsiella pneumoniae (KP) is a common hospital-acquired and community-acquired pathogen. In recent years, patients with liver abscess caused by KP and accompanying extrahepatic infection have gradually increased, and causing widespread concern. The pathogen, which caused liver abscess, and characterized by high virulance and high mucinous, is easy to cause infection among healthy individual. Therefore, it is defined as hypervirulent Klebsiella pneumoniae (hvKP). Compared with classic Klebsiella pneumoniae (cKP), the clinical characteristics of hvKP infection, sensitivity to antibiotics, and molecular biological characteristics are significantly different. It will be a fine way to understand the pathogenic mechanism of the bacteria by studying the virulence gene of hvKP, which may help to early diagnose and medical treatment of the infection caused by the bacteria, and will effectively improve the prognosis of patients with hvKP infection.

[1]
Ye M, Tu J, Bi Y, et al. Clinical and genomic analysis of liver abscess-causing Klebsiella pneumoniae identifies new liver abscess-associated virulence genes[J]. Front Cell Infect Microbiol,2016,6:165.
[2]
Liu YC, Cheng DL, Lin CL. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis[J]. Arch Intern Med,1986,146(10):1913-1916.
[3]
Patel PK, Russo TA, Karchmer AW. Hypervirulent Klebsiella pneumoniae[J]. Open Forum Infect Dis,2014,1(1):ofu028.
[4]
Liu YM, Li BB, Zhang W, te al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China[J]. Antimicrob Agent Chemother,2014,58(9):5379-5385.
[5]
Namikawa H, Yamada K, Fujimoto H, et al. Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome[J]. BMC Infect Dis,2016,16(1):680.
[6]
Tan TY, Ong M, Cheng Y, et al. Hypermucoviscosity, rmpA, and aerobactin are associated with community-acquired Klebsiella pneumoniae bacteremic isolates causing liver abscess in Singapore[J]. J Microbiol Immunol Infect,2019,52(1):30-34.
[7]
Remya P, Shanthi M, Sekar U. Occurrence and characterization of hyperviscous K1 and K2 serotype in Klebsiella pneumoniae[J]. J Lab Physicians,2018,10(3):283-288.
[8]
Khaertynov KS, Anokhin VA, Rizvanov AA, et al. Virulence factors and antibiotic resistance of Klebsiella pneumoniae strains isolated from neonates with sepsis[J]. Front Med (Lausanne),2018,5:225.
[9]
Qu TT, Zhou JC, Jiang Y, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in East China[J]. BMC Infect Dis,2015,15(1):161.
[10]
Hsu CR, Lin TL, Chen YC, et al. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited[J]. Microbiology,2011,157(12):3446-3457.
[11]
Nassif X, Fournier JM, Arondel J, et al. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor[J]. Infect Immun,1989,57(2):546-552.
[12]
Shankar C, Veerarghavan B, Leb N, et al. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection[J]. BMC Microbiol,2018,18(1):6.
[13]
Zhang Y, Zhao C, Wang Q, et al. High prevalence of Hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance[J]. Antimicrob Agents Chemother,2016,60(10):6115-6120.
[14]
Zhang R, Lin D, Chan EW, et al. Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China[J]. Antimicrob Agents Chemother,2016,60(1):709-711.
[15]
Melot B, Brisse S, Breurec S, et al. Community-acquired meningitis caused by a CG86 hypervirulent Klebsiella pneumoniae strain: first case report in the Caribbean[J]. BMC Infect Dis,2016,16(1):736.
[16]
Yu WL, Ko WC, Cheng KC, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumonia in Taiwan[J]. Clin Infect Dis,2006,42(10):1153-1358.
[17]
Lamb AL. Breaking a pathogen’s iron will: Inhibiting siderophore production as an antimicrobial strategy[J]. Biochim Biophys Acta,2015,1854(8):1054-1070.
[18]
Struve C, Roe CC, Stegger M, et al. Mapping the evolution of hypervirulent Klebsiella pneumoniae[J]. MBio,2015,6(4):e00630.
[19]
Russo TA Olsen R, Macdonald U, et al. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae[J]. Infect Immun,2014,82(6):2356-2367.
[20]
Baily DC, Drake EJ, Grant TD, et al. Structural and functional characterization of aerobactin synthetase IucA from a hypervirulent pathotype of Klebsiella pneumoniae[J]. Biochemistry,2016,55(25):3559-3570.
[21]
Rosso TA, Olsen R, Macdonald U, et al. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo[J]. Infect Immun,2015,83(8):3325-33.
[22]
Li W, Sun W, Yu Y, et al. Increasing occurrence of antimicrobial resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China[J]. Clin Infec Dis,2014,58(2):225-232.
[23]
Compain F, Babosan A, Brisse S, et al. Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumonia[J]. J Clin Microbiol,2014,52(12):4377-4380.
[24]
Wang XL, Xie YZ, Li G, et al. Whole-genome-sequencing characterization of bloodstream infection-causing hypervirulent Klebsiella pneumoniae of capsular serotype K2 and ST374[J]. Virulence,2018,9(1):510-521.
[25]
Li W, Sun GZ, Yu YH, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China[J]. Clin Infect Dis,2014,58(2):225-232.
[26]
章丹,余方友. 血流感染高毒力肺炎克雷伯菌的临床危险因素及耐药性分析[J]. 中国卫生检验杂志,2017,27(16):2353-2361.
[27]
汪强,葛玉梅,刘建芳, 等. 肝脓肿高毒力肺炎克雷伯菌耐药性及毒力基因型流行性分析[J]. 中华医院感染学杂志,2016,26(24):5531-5586.
[28]
Wei DD, Wan LG, Liu Y. Draft genome sequence of an NDM-1- and KPC-2-Coproducing hypervirulent carbapenem-resistant Klebsiella pneumoniae strain isolated from burn wound infections[J]. Genome Announc,2018,6(13):e00192-18.
[1] 岳靖林, 滑明溪, 段昂, 杜鹏程, 霍成, 陈晨. 艰难梭菌耐药基因、毒力基因分布与核心基因的功能特征[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(06): 409-418.
[2] 张玲, 孙月, 陈勇, 郜桂菊, 杨思园, 万康林, 李兴旺. 获得性免疫缺陷综合征合并结核病患者对结核分枝杆菌二线药物耐药特征分析[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(02): 166-172.
阅读次数
全文


摘要